Breakthrough in Colon Cancer Treatment: Can an Old Anti-Inflammatory Reduce Recurrence Risk?
2025-01-31Reuters
A promising new study reveals that patients with colon cancer may be able to reduce their risk of cancer recurrence with the daily use of celecoxib, a nonsteroidal anti-inflammatory pill. This breakthrough research suggests that celecoxib may improve ...Read more
Recommendations
Loading...